<DOC>
	<DOCNO>NCT00337051</DOCNO>
	<brief_summary>Renal transplantation characterize ischemia-reperfusion lesion allograft . In previous study , Julier al . ( Anesthesiology 2003 ) demonstrate sevoflurane reduces glomerular lesion kidney patient undergo cardiovascular surgery présenting ischemia-reperfusion phenomenon . The purpose study evaluate effect sevoflurane recovery renal graft function patient kidney transplantation . This study randomize , double blind , control clinical trial 120 patient undergoing renal allograft transplantation include . Patients divide 2 group : one group patient receive sevoflurane ( evaluated treatment ) anaesthesia one receive propofol ( reference treatment ) . We evaluate renal function one year transplantation . Ours result confirm sevoflurane protects kidney function ischemia-reperfusion lesion .</brief_summary>
	<brief_title>Renal Transplantation Inhaled Anesthetic Sevoflurane ( SEVOREIN )</brief_title>
	<detailed_description>Introduction : Renal transplantation characterize ischemia-reperfusion lesion allograft . Prolonged cold ischemia duration , age donor ( old 50 ) donor cardiac arrest common factor associate delayed graft function . In cardiac surgery , Sevoflurane ( volatile-inhaled anesthetic ) protect heart ischemia-reperfusion lesion preserve glomerular filtration function patient . This cardioprotective effect involve K+-ATP mitochondrial channel also know express renal cell . Therefore , interest evaluate Sevoflurane effect context renal allograft transplantation order shorten delay graft function enhance post-operative renal function Objectives : Main goal : Evaluate time necessary obtain serum creatinine level inferior 200µmol/l recipient group receive Sevoflurane comparison group patient receive propofol infusion general anaesthesia Secondary goal : - Compare serum creatinine level two group day14 - Compare patient survival acute rejection occurrence period one-year follow-up two group - Compare safety anesthetic assess renal tubular injury-toxicity ( measure serum level NAG ) level serum inorganic fluor product post-operative period ; reference adverse event - Compare effect anesthetic delayed-recovery graft function assess clinical end-points ( daily diuresis , number haemodialysis session two week follow transplantation ) biological end-points ( serum creatinin cystatinC level two week follow transplantation ) Patients : 120 patient schedule undergo renal allograft transplantation transplant define either cold ischemia duration 20h donor 's age older 50 year donor cardiac arrest randomize 2 group sixty patient undergo two different general anesthesia protocol . All patient include Renal Transplantation Unit Bordeaux University Hospital , Aquitaine , France . Methods : This study clinical randomize trial 2 parallel group . It double-blind nephrologists biologist evaluate end-points involve population renal transplant patient . The study compare clinical biological outcome accord type general anesthesia undergone transplantation : - One group patient inhale anesthesia Sevoflurane ( evaluate treatment ) - One group patient intravenous anesthesia propofol ( reference treatment ) . Patients evaluate period one year follow-up . This study multicentric , base Aquitaine period three year , involve anaesthesiologists , nephrologists , urologist . Baseline brain-dead donor graft donation characteristic collect Hospital Coordination team Bordeaux , Pau Bayonne . Statistical analysis intention-to-treat basis . Expected result : 1-Demonstrate Sevoflurane benefit ischemia-reperfusion protection renal allograft shorten recovery renal graft function two-week post-operative period group allocate Sevoflurane exposure anaesthesia . 2-Confirm good safety Sevoflurane exposure chronic end-stage renal diseased patient undergoing renal transplantation .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>age &gt; 18 year schedule undergo renal allograft transplantation transplant : cold ischemia duration &gt; 20 hour donor age &gt; 50 year donor cardiac arrest ASA 23 social security affiliation inform consent sign halogenated anesthetic agent hypersensibility medical history familial history malignant hyperthermia porphyria pregnancy breast feed hyperimmunized patient participation immunosuppressive drug trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Renal transplantation</keyword>
	<keyword>renal allograft</keyword>
	<keyword>end-stage renal disease</keyword>
	<keyword>renal failure</keyword>
	<keyword>general anaesthesia</keyword>
	<keyword>inhale anaesthetic</keyword>
	<keyword>Sevoflurane</keyword>
	<keyword>ischemia</keyword>
	<keyword>reperfusion</keyword>
	<keyword>ischemic lesion</keyword>
</DOC>